MyShare
Indices
| index | last | change | % |
| Dow Jones | |||
| SP 500 | |||
| NASDAQ | |||
| VIX | |||
| VIX Tail | |||
| All Ords | |||
| US 10 Year | |||
| US 2 Year |
Rates
| index | last | change | % |
| Bitcoin | |||
| Ethereum | |||
| AUD/USD | |||
| GBP/USD | |||
| EURUSD | |||
| JPYUSD |
Commodity
| index | last | change | % |
| Brent Cruide | |||
| Silver | |||
| GOLD |
Top news stories
| News | date | |
| $ICPT - Intercept Pharmaceuticals posts Q2 earnings beat on Ocaliva Strength, shares rise https://t.co/NCNzpxVFAb $ICPT - Intercept Pharmaceuticals posts Q2 earnings beat on Ocaliva Strength, shares rise https://t.co/NCNzpxVFAb | @MarketCurrents Thu 12:04 ICPT US | |
| Ribbon Communications Inc. (RBBN) Q2 2021 Earnings Call Transcript RBBN earnings call for the period ending June 30, 2021. | fool Thu 12:03 RBBN US | |
| Brightcove (BCOV) Q2 2021 Earnings Call Transcript BCOV earnings call for the period ending June 30, 2021. | fool Thu 12:02 BCOV US | |
| Aqua Metals Signs Definitive Agreement with ACME Metal Enterprise to Deploy AquaRefining Technology in Taiwan Company Preparing to Ship AquaRefining Equipment for First Deployment Company Preparing to Ship AquaRefining Equipment for First Deployment | globenewswire Thu 12:01 AQMS US | |
| Artio Medical Successfully Completes Enrollment of First-in-Human Trial Investigating the Amplifi Vein Dilation System PRAIRIE VILLAGE, Kan., July 29, 2021 /PRNewswire/ -- Artio Medical, Inc., a medical device company developing innovative products for the peripheral vascular, neurovascular, and structural heart markets, announced today it has completed enrollment in its first-in-human study evaluating... | prnewswire:443 Thu 12:01 ART US | |
| Arbutus to Report Second Quarter 2021 Financial Results and Provide Corporate Update WARMINSTER, Pa., July 29, 2021 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company primarily focused on discovering, developing and commercializing a cure for people with chronic hepatitis B virus (HBV) infection, as well as therapies to treat coronaviruses (including COVID-19), today announced that it has scheduled its second quarter 2021 financial results and corporate update for Thursday, August 5, 2021. The schedule for the press release and conference call/webcast are as follows: | globenewswire Thu 12:00 ABUS US | |
| CytomX Therapeutics to Announce Second Quarter 2021 Financial Results on August 5, 2021 SOUTH SAN FRANCISCO, Calif., July 29, 2021 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investigational conditionally activated therapeutics based on its Probody technology platform, today announced that it will report second quarter 2021 financial results onThursday, August 5, 2021, after the close of U.S. markets. Following the announcement, the Company will host a conference call and webcast at5:00 p.m. ET/2:00 p.m. PTto discuss the results and provide a corporate update. | globenewswire Thu 12:00 CTMX US | |
| Augmenta Bioworks and TFF Pharmaceuticals Announce Positive In Vitro Data Demonstrating Binding and Neutralization of the SARS-CoV-2 Delta Variant by Lead Anti-COVID-19 Antibody, AUG-3387 Data Shows AUG-3387 Neutralizes SARS-CoV-2 Delta Variant in Infective Assays | globenewswire Thu 12:00 TFFP US | |
| : CyrusOne double upgraded to outperform from underperform at Raymond James This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news. | marketwatch Thu 11:56 CONE US | |
| : Altice USA downgraded to outperform from strong buy at Raymond James This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news. | marketwatch Thu 11:53 ATUS US | |
| $AVXL (+7.3% pre) Anavex Life Sciences Announces ANAVEX2-73 (Blarcamesine) Significantly Prevented A (Abeta)-indu https://t.co/ENobfAAaCB $AVXL (+7.3% pre) Anavex Life Sciences Announces ANAVEX2-73 (Blarcamesine) Significantly Prevented A (Abeta)-indu https://t.co/ENobfAAaCB | @OpenOutcrier Thu 11:51 AVXL US | |
| $CTXS - Citrix slumps after Q2 revenue misses, lowered full-year outlook https://t.co/g1ujYiql4r $CTXS - Citrix slumps after Q2 revenue misses, lowered full-year outlook https://t.co/g1ujYiql4r | @MarketCurrents Thu 11:35 CTXS US | |
| Watch these movies & shows before they leave Netflix this week https://t.co/eiLajVhc09 Watch these movies & shows before they leave Netflix this week https://t.co/eiLajVhc09 | @TeenVogue Thu 11:35 NFLX US | |
| Salarius Pharmaceuticals to Report Second Quarter 2021 Financial Results Conference Call and Live Audio Webcast Scheduled for Thursday, August 5, 2021, 10:00 a.m. ET Conference Call and Live Audio Webcast Scheduled for Thursday, August 5, 2021, 10:00 a.m. ET | globenewswire Thu 11:33 SLRX US | |
| $BPMC - Blueprint Medicines EPS misses by $0.05, beats on revenue https://t.co/7aIRb4cQHn $BPMC - Blueprint Medicines EPS misses by $0.05, beats on revenue https://t.co/7aIRb4cQHn | @MarketCurrents Thu 11:08 BPMC US | |
| : Altria Q2 cigarettes shipments up 1.4% to 25.31 bln sticks This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news. | marketwatch Thu 11:05 MO US | |
| Provention Bio to Report Second Quarter 2021 Financial Results on August 5, 2021 RED BANK, N.J., July 29, 2021 /PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today announced that it will report its second quarter 2021 financial results on Thursday, August 5, 2021,... | prnewswire:443 Thu 11:00 PRVB US | |
| OneWater Marine Inc. Announces Fiscal Third Quarter 2021 Results Strong Execution Drove Significant Margin Expansion and Earnings Growth | globenewswire Thu 11:00 ONEW US | |
| Genocea Provides Second Quarter 2021 Corporate Update GEN-011 neoantigen-targeted peripheral T cell therapy clinical trial continues | globenewswire Thu 11:00 GNCA US | |
| Calithera Biosciences to Report Second Quarter 2021 Financial Results on Thursday, August 5, 2021 SOUTH SAN FRANCISCO, Calif., July 29, 2021 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a fully-integrated clinical-stage biotechnology company focused on discovering and developing novel, small molecule drugs for the treatment of cancer and other life-threatening diseases, today announced that the Companys second quarter 2021 financial results will be released on Thursday, August 5, 2021. Company management will host a conference call on Thursday, August 5, 2021 at 2:00 p.m. Pacific Time/ 5:00 p.m. Eastern Time to discuss the financial results and other recent corporate highlights. | globenewswire Thu 11:00 CALA US |